By 
                Liz Highleyman
              
              
                 
                  |  | 
                
                  | 
                      
                        |  
                            Nick Panagopoulos 
                            (at podium) presents mayoral proclamation recognizing 
                            World Hepatitis Day to SF Hepatitis C Task Force co-chairs 
                            Randy Allgaier (left of podium) and Dominique Leslie.(Photo: Liz Highleyman)
 |  | 
              
              "We're 
                here to give a voice and a face to a disease that remains in the 
                shadows," said Randy Allgaier, co-chair of the [San Francisco 
                Hepatitis C Task Force[http://www.hepcsf.org], speaking from the 
                steps of City Hall. "San Francisco must move out of the shadows 
                of this silent epidemic, because as we learned with HIV, silence 
                equals death."
              The 
                local rally brought out about 50 activists under an unseasonable 
                light rain.
                Nick Panagopoulos from the office of Mayor Gavin Newsom -- who 
                spearheaded the creation of the task force -- and Alex Randolph, 
                aide to Supervisor Bevan Dufty, both presented proclamations recognizing 
                World Hepatitis Day.
              While 
                the rally focused on hepatitis C, Allgaier applauded the new Hep 
                B Free campaign which aims to raise awareness among the city's 
                large Asian community, a group at especially high risk for hepatitis 
                B.
              Task 
                force co-chair Dominique Leslie related her journey with hepatitis 
                C, reflecting issues faced by many people with the disease. Leslie 
                was diagnosed with non-A/non-B hepatitis in 1988, the year before 
                the hepatitis C virus (HCV) was discovered. At the time, she was 
                told not to worry and that she didn't need to do anything. By 
                2000, she began to develop symptoms of liver disease, but was 
                told they were not due to HCV. Since then, she said she has been 
                denied treatment twice because she is transgender, and she is 
                now on the liver transplant waiting list.
              "I 
                joined the task force so other people don't have to go through 
                what I face," she said. "I've been clean and sober for 
                more than 20 years, but active drug users are being denied treatment 
                and access to clinical trials."
              Other 
                speakers represented the diverse face of hepatitis C. Todd is 
                an HIV positive former methamphetamine user who never used needles 
                and believes he got HCV through sex. Today he is clean and sober, 
                and both his HIV and HCV are undetectable, but "it was no 
                picnic getting there," he said. 
              Robin, 
                an older woman who was diagnosed with hepatitis C years ago, has 
                been free of the virus for 8 years with the help of holistic therapy 
                including acupuncture. "HCV is the first virus for which 
                we have a cure, but unfortunately the treatments are very difficult 
                and they don't work for everyone," she said.
              Jack 
                and Havoc are 2 young men involved with UCSF's 
                UFO Project for young injection drug users. Jack started interferon, 
                but lasted only 3 months due to side effects; against all odds, 
                however, he managed to clear HCV anyway. But Havoc, a member of 
                San Francisco's new Drug 
                Users Union, lacks permanent housing, has not been able to 
                get on interferon treatment, and his liver disease is progressing.
              Finally, 
                Karen Aziz compared her experiences as a woman dually diagnosed 
                with hepatitis C and breast cancer. When she learned she had breast 
                cancer, she recalled, she was told about all the available treatment 
                options and referred to a support group. 
              "Companies 
                sponsor walks for research, you see uplifting commercials, patients 
                are lauded as heroes, and everyone shows compassion," she 
                said. "It's quite the opposite for hepatitis C. "No 
                company wants to sponsor a race for the cure for this disease. 
                Our struggles are secret, silent, and lonely. We need funding 
                for full medical care for everyone who needs it so a diagnosis 
                of hepatitis C need not be a death sentence."
              
              
              
              
               Below 
                is a press release from the National Viral Hepatitis Roundtable 
                about the Washington rally. 
              On 
                World Hepatitis Day 2010, NVHR Capitol Hill Rally Attracts
                Hundreds of Americans & Five Members of Congress to 
                Support Increased Federal Funding for Viral Hepatitis
              Washington, 
                DC -- May 19 -- Surrounded by a diverse group of 500 Americans 
                from the viral hepatitis B and C communities united in common 
                purpose on World Hepatitis Day 2010, the National Viral Hepatitis 
                Roundtable (NVHR) today hosted a Capitol Hill rally urging swift 
                action to fix the federal funding crisis for 5 million Americans 
                afflicted with chronic viral hepatitis. With the support of a 
                boisterous crowd, NVHR was joined by five Members of Congress, 
                Congressmen Hank Johnson (D-Ga.), Mike Honda (D-Calif.), Charles 
                Dent (R-Pa.), Anh "Joseph" Cao (R-La.), and Mike Cassidy, 
                M.D. (R-La.), whom all pledged to make the promise of increased 
                federal funding a reality this year and to address the viral hepatitis 
                funding problem once and for all. 
                
                "NVHR has a simple and direct message for Washington: we 
                are not going away and we will no longer be ignored. Until Congress 
                and the Administration act once and for all to fix the funding 
                crisis, we will be unrelenting in demanding adequate federal funding 
                for viral hepatitis screening, education, and intervention programs 
                for 5 million Americans," vowed Ms. Lorren Sandt, NVHR Chair 
                and Executive Director of Caring Ambassadors Program, based in 
                Portland, OR. "In the absence of federal leadership, the 
                annual costs of viral hepatitis to Medicare and Medicaid could 
                reach $85 billion in the coming decade. Swift federal action now 
                will help millions of Americans and help mitigate an otherwise 
                inevitable fiscal disaster. The time for action is now. Our community 
                and our nation cannot afford any more delays."
                
                Today's rally featured 500 Americans from all walks of life united 
                in their cause to urge Washington to act. Representing 11 states 
                and the District of Columbia, the rally featured speakers representing 
                NVHR, the National Alliance of State and Territorial AIDS Directors, 
                the District of Columbia Department of Health, Veterans Aimed 
                towards Awareness, the Association of Asian Pacific Community 
                Health Organizations, Community AIDS National Network, Hepatitis 
                B Foundation, Greater Washington Viral Hepatitis Support Group, 
                Harm Reduction Coalition, North General Hospital, Hepatitis Education 
                Program, Chinese American Medical Society, Hepatitis B Initiative-DC, 
                National AIDS Treatment Advocacy Project, Hepatitis C Support 
                Project, Hepatitis C Association, and many others. The rally also 
                featured a Silent Vigil in tribute to those individuals lost to 
                hepatitis B or C.
                
                Approximately 1 in 50 Americans are afflicted with chronic viral 
                hepatitis B or C -- with most unaware they are infected, especially 
                African Americans and Asian Americans. Without detection and treatment, 
                chronic viral hepatitis leads to liver cancer, cirrhosis, or liver 
                failure. In the absence of federal leadership, the research firm 
                Milliman estimates that public and private payers' cost of treating 
                chronic viral hepatitis C alone will more than triple by 2024 
                to $85 billion annually. Medicare and Medicaid would absorb a 
                disproportionate share of these added costs. 
                
                Earlier this year, the Institute 
                of Medicine (IOM) released a landmark report blasting the 
                federal government for its inadequate response to this crisis. 
                Since the January 2010 release of the IOM report, the Administration 
                has done little to help assuage the viral hepatitis community. 
                The Administration's budget proposal for 2011 would fund the Division 
                of Viral Hepatitis at a level actually lower than allocated a 
                decade ago during the Clinton Administration. 
                
                Bipartisan legislation, HR 3974, "The Viral Hepatitis and 
                Liver Cancer Control and Prevention Act," sponsored by Representatives 
                Mike Honda (D-Calif.), Charles Dent (R-Pa.) and 36 other House 
                Members would correct this shortfall. The Honda-Dent legislation 
                would increase the ability of the CDC to support state health 
                departments in their prevention, immunization and surveillance, 
                and referral to care efforts. Much of the Honda-Dent legislation 
                tracks with the IoM's recommendations. 
                
                NVHR is a coalition of more than 150 public, private, and voluntary 
                organizations dedicated to reducing the incidence of infection, 
                morbidity, and mortality from chronic viral hepatitis that afflicts 
                more than 5 million Americans. For more information, visit www.nvhr.org. 
                 
              5/21/10
              Source
                National 
                Viral Hepatitis Roundtable. On World Hepatitis Day 2010, NVHR 
                Capitol Hill Rally Attracts Hundreds of Americans & Five Members 
                of Congress To Support Increased Federal Funding for Viral Hepatitis. 
                Press release. May 19, 2010.